Pfizer says COVID-19 vaccine more than 90pc effective in kids

Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91 per cent effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the US considers opening vaccinations to that age group.

सम्बन्धित सामग्री

US donates Pfizer pediatric COVID-19 vaccine to Bhutan

In order to curb the spread of COVID-19, the United States delivered 33,600 doses of the Pfizer pediatric COVID-19 vaccine to Bhutan

COVID-19 vaccine to 5-12 age group from today

Children aged between 5 to 12 years are being administered the Pfizer BioNTech COVID-19 vaccine from Thursday across the country

Pfizer profit soars in first quarter, revises 2022 forecast

COVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street’s first-quarter expectations, as the drugmaker’s profit grew 61%.

COVID vaccine gets weak antibody while on immunosuppressants

A new study has found that people who received two doses of the Pfizer COVID-19 vaccine while on TNF inhibitors.

Biden gets COVID-19 vaccine booster shot

WASHINGTON, Sept. 28: U.S. President Joe Biden on Monday received his COVID-19 vaccine booster shot on camera at the White House. "Boosters are important, but the most important thing we need to do is get more people vaccinated," Biden said before getting his booster shot. About 23 percent of eligible Americans haven't gotten any shot, said the president. Some 20 million Americans are eligible for a third shot of the Pfizer vaccine, according to a CNN report. The U.S. Centers for Disease Control and Prevention (CDC) last week recommended Pfizer boosters for older adults, long-term care facility residents, some people with underlying health conditions and adults at increased risk of COVID-19 because of their jobs.

Pfizer says its vaccine works in kids aged 5 to 11 yrs

Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11.

Pfizer COVID-19 vaccines gets approval for emergency use among children in Nepal

KATHMANDU, September 12: The Pfizer COVID-19 vaccine has been granted approval for emergency use against the novel coronavirus disease (COVID-19) in Nepal. The Department of Drugs Administrations (DDA) has granted the approval to administer Pfizer COVID-19 vaccines among childrens in Nepal. “The DDA has granted permission to distribute Pfizer COVID-19 vaccines through the Ministry of Health and Population (MoHP),” said Narayan Prasad Dhakal, Director General of the department. “The government can now procure the Pfizer COVID-19 vaccines and administer it among childrens.” The government has begun preparations to administer Pfizer COVID-19 vaccines to children who are more than 12 years old. Nepal is scheduled to receive 100,000 doses of Pfizer COVID-19 vaccines in a few days through the COVAX facility. So far, along with the Pfizer COVID-19 vaccine, Covishield, Vero Cell, J & J and Astrazeneca vaccines have been given approval for emergency use against COVID-19. (With inputs from Annapurna Post)